A Phase II Pilot Study Of Yttrium-90 In Combination With Capecitabine And Atezolizumab For Oligometastatic Colorectal Cancer With Unresectable Liver Metastases (METEORITE)
A Phase 1 Open-Label Study of PF-07934040 as a Single-Agent and in Combination With Other Targeted Agents in Participants with Advanced Solid Tumors Harboring Mutations in the KRAS Gene.
RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection (BNNT1222-01)
A Phase 1, Two-Part, Multicenter, Open-Label First-in-Human Study of anti-CEACAM5 Antibody-Drug Conjugate M9140 in Participants with Advanced Solid Tumors